News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) Buys BioImagene, Inc. For $100 Mln, Boosts Diagnostics


8/23/2010 7:05:17 AM

ZURICH, Aug 23 (Reuters) - Swiss drugmaker Roche Holding AG (ROG.VX) is buying U.S-based BioImagene for some $100 million, making another bolt-on acquisition to cement its dominant position in tissue-based cancer diagnostics.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES